Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)

Clinical trial NCT00344513 · COMPLETED

Trial details

NCT number: NCT00344513
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure, Congestive

Start date: 2002-12-16
Enrollment: 50000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.